# Foresite Capital's Biotech Investments: 68 Startups in Its Portfolio (2026) > The 68 Biotech startups Foresite Capital has backed, by stage: $13B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/forsite-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 20 - [Relay Therapeutics](https://millionrounds.com/company/relay-therapeutics) - [Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences) - [Orchard Therapeutics](https://millionrounds.com/company/orchard-therapeutics) - [Eikon Therapeutics](https://millionrounds.com/company/eikon-therapeutics) - [Solid Biosciences](https://millionrounds.com/company/solid-biosciences) - [bit.bio](https://millionrounds.com/company/bit-bio) - [LifeMine Therapeutics](https://millionrounds.com/company/lifemine-therapeutics) - [Alector](https://millionrounds.com/company/alector) - [Obsidian Therapeutics](https://millionrounds.com/company/obsidian-therapeutics) - [Peloton Therapeutics](https://millionrounds.com/company/peloton-therapeutics) - [Decibel Therapeutics](https://millionrounds.com/company/decibel-therapeutics) - [DNAnexus](https://millionrounds.com/company/dnanexus) - [Genapsys](https://millionrounds.com/company/genapsys) - [*TT* TP Therapeutics](https://millionrounds.com/company/tp-therapeutics) - [Ivantis](https://millionrounds.com/company/ivantis) - [Protagonist Therapeutics](https://millionrounds.com/company/protagonist-therapeutics) - [Cerevance](https://millionrounds.com/company/cerevance) - [PACT Pharma](https://millionrounds.com/company/pact-pharma) - [*O* ORIC](https://millionrounds.com/company/oric) - [HealthVerity](https://millionrounds.com/company/healthverity) ## Stage not reported 18 - [*TP* Turning Point Therapeutics](https://millionrounds.com/company/turning-point-therapeutics) - [Alumis](https://millionrounds.com/company/alumis) - [Nurix Therapeutics](https://millionrounds.com/company/nurix-therapeutics) - [Rapt Therapeutics](https://millionrounds.com/company/rapt-therapeutics) - [CG Oncology](https://millionrounds.com/company/cg-oncology) - [10X Genomics](https://millionrounds.com/company/10x-genomics) - [*I* Inscripta](https://millionrounds.com/company/inscripta) - [AtaiBeckley](https://millionrounds.com/company/ataibeckley) - [Replimune Group](https://millionrounds.com/company/replimune-group) - [Invivyd](https://millionrounds.com/company/invivyd) - [Pardes Biosciences](https://millionrounds.com/company/pardes-biosciences) - [Aetion](https://millionrounds.com/company/aetion) - [Remix Therapeutics](https://millionrounds.com/company/remix-therapeutics) - [Quantum SI](https://millionrounds.com/company/quantum-si) - [Sequenta](https://millionrounds.com/company/sequenta) - [Mirvie](https://millionrounds.com/company/mirvie) - [ImmPACT Bio](https://millionrounds.com/company/immpact-bio) - [Tempest Therapeutics](https://millionrounds.com/company/tempest-therapeutics) ## Series B 16 - [Intellia Therapeutics](https://millionrounds.com/company/intellia-therapeutics) - [Wave Life Sciences](https://millionrounds.com/company/wave-life-sciences) - [Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics) - [Fulcrum Therapeutics](https://millionrounds.com/company/fulcrum-therapeutics) - [Generation Bio](https://millionrounds.com/company/generation-bio) - [Keros Therapeutics](https://millionrounds.com/company/keros-therapeutics) - [Pharvaris](https://millionrounds.com/company/pharvaris) - [*J* Juvenescence](https://millionrounds.com/company/juvenescence) - [Tarsa Therapeutics](https://millionrounds.com/company/tarsa-therapeutics) - [Kinnate Biopharma](https://millionrounds.com/company/kinnate-biopharma) - [Avenzo Therapeutics](https://millionrounds.com/company/avenzo-therapeutics) - [Kira Pharmaceuticals](https://millionrounds.com/company/kira-pharmaceuticals) - [*KT* Khartis Therapeutics](https://millionrounds.com/company/khartis-therapeutics) - [XinThera](https://millionrounds.com/company/xinthera) - [*V* VentaoRX](https://millionrounds.com/company/ventaorx) - [Foresight Diagnostics](https://millionrounds.com/company/foresight-diagnostics) ## Series A 9 - [Tango Therapeutics](https://millionrounds.com/company/tango-therapeutics) - [*GT* Gemini Therapeutics](https://millionrounds.com/company/gemini-therapeutics) - [Slate Medicines](https://millionrounds.com/company/slate-medicines) - [RayThera](https://millionrounds.com/company/raythera) - [Nested Therapeutics](https://millionrounds.com/company/nested-therapeutics) - [Velia](https://millionrounds.com/company/velia) - [Third Arc Bio](https://millionrounds.com/company/third-arc-bio) - [Spear Bio](https://millionrounds.com/company/spear-bio) - [TenSixteen Bio](https://millionrounds.com/company/tensixteen-bio) ## Pre-seed and seed 3 - [Indomo](https://millionrounds.com/company/indomo) - [Tempest](https://millionrounds.com/company/tempest) - [Sutro](https://millionrounds.com/company/sutro) ## Growth 2 - [Intarcia Therapeutics](https://millionrounds.com/company/intarcia-therapeutics) - [Element Biosciences](https://millionrounds.com/company/element-biosciences) ## Segment by segment ### Series C and later 20 startups · $4.6B raised - [**Relay Therapeutics**](https://millionrounds.com/company/relay-therapeutics) Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion. United States $932M - [**Arcus Biosciences**](https://millionrounds.com/company/arcus-biosciences) Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer. United States $427M - [**Orchard Therapeutics**](https://millionrounds.com/company/orchard-therapeutics) Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies. United Kingdom $377M - [**Eikon Therapeutics**](https://millionrounds.com/company/eikon-therapeutics) Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery. United States $351M - [**Solid Biosciences**](https://millionrounds.com/company/solid-biosciences) Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy. United States $333M - [**bit.bio**](https://millionrounds.com/company/bit-bio) bit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom. United Kingdom $264M - [**LifeMine Therapeutics**](https://millionrounds.com/company/lifemine-therapeutics) LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines. United States $230M - [**Alector**](https://millionrounds.com/company/alector) Alector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases. United States $215M ### Stage not reported 18 startups · $2.7B raised - [*TP* **Turning Point Therapeutics**](https://millionrounds.com/company/turning-point-therapeutics) Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases. - $460M - [**Alumis**](https://millionrounds.com/company/alumis) Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders. United States $345M - [**Nurix Therapeutics**](https://millionrounds.com/company/nurix-therapeutics) Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs. United States $250M - [**Rapt Therapeutics**](https://millionrounds.com/company/rapt-therapeutics) Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer. United States $250M - [**CG Oncology**](https://millionrounds.com/company/cg-oncology) CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer. United States $238M - [**10X Genomics**](https://millionrounds.com/company/10x-genomics) 10X Genomics ELV solutions and security systems company that provides an innovative genomics platform. United States $215M - [*I* **Inscripta**](https://millionrounds.com/company/inscripta) United States $205M - [**AtaiBeckley**](https://millionrounds.com/company/ataibeckley) AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs. Germany $150M ### Series B 16 startups · $2.6B raised - [**Intellia Therapeutics**](https://millionrounds.com/company/intellia-therapeutics) Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. United States $485M - [**Wave Life Sciences**](https://millionrounds.com/company/wave-life-sciences) Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling United States $434M - [**Beam Therapeutics**](https://millionrounds.com/company/beam-therapeutics) Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology. United States $322M - [**Fulcrum Therapeutics**](https://millionrounds.com/company/fulcrum-therapeutics) Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause. United States $310M - [**Generation Bio**](https://millionrounds.com/company/generation-bio) Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders. United States $176M - [**Keros Therapeutics**](https://millionrounds.com/company/keros-therapeutics) Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments. United States $163M - [**Pharvaris**](https://millionrounds.com/company/pharvaris) Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients. Switzerland $132M - [*J* **Juvenescence**](https://millionrounds.com/company/juvenescence) Ireland $126M ### Series A 9 startups · $1.5B raised - [**Tango Therapeutics**](https://millionrounds.com/company/tango-therapeutics) Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies. United States $852M - [*GT* **Gemini Therapeutics**](https://millionrounds.com/company/gemini-therapeutics) Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. United States $138M - [**Slate Medicines**](https://millionrounds.com/company/slate-medicines) Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention. United States $130M - [**RayThera**](https://millionrounds.com/company/raythera) RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology. United States $110M - [**Nested Therapeutics**](https://millionrounds.com/company/nested-therapeutics) Nested Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. United States $90M - [**Velia**](https://millionrounds.com/company/velia) Velia is a biotech company that discovers and develops the therapeutic potential of human proteins. United States $55M - [**Third Arc Bio**](https://millionrounds.com/company/third-arc-bio) Third Arc Bio is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, founded in 2022. United States $52M - [**Spear Bio**](https://millionrounds.com/company/spear-bio) Spear Bio is a biotechnology startup based in Woburn, Massachusetts, founded in 2021. United States $45M ### Pre-seed and seed 3 startups · $30M raised - [**Indomo**](https://millionrounds.com/company/indomo) Indomo is a clinical-stage therapeutics company based in San Francisco, California, focused on developing innovative treatments fo United States $25M - [**Tempest**](https://millionrounds.com/company/tempest) Tempest is a Celtic rock band based in the San Francisco Bay Area, active since 1988. United States $3.2M - [**Sutro**](https://millionrounds.com/company/sutro) Sutro, Inc. United States $2.2M ### Growth 2 startups · $1.3B raised - [**Intarcia Therapeutics**](https://millionrounds.com/company/intarcia-therapeutics) Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment. United States $1.1B - [**Element Biosciences**](https://millionrounds.com/company/element-biosciences) Element Biosciences is a biotechnology company based in San Diego, founded in 2017 by former Illumina scientists. United States $190M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Foresite Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Foresite Capital's Pharma portfolio** 12 startups · $2.2B](https://millionrounds.com/portfolio-maps/forsite-capital-pharma-portfolio)[Sector portfolio **Foresite Capital's Healthtech portfolio** 10 startups · $973M](https://millionrounds.com/portfolio-maps/forsite-capital-healthtech-portfolio)[Portfolio map **Foresite Capital portfolio map** 91 startups · $17B](https://millionrounds.com/portfolio-maps/forsite-capital-portfolio-map)[Co-investors **Who invests with Foresite Capital** 77 co-investors](https://millionrounds.com/portfolio-maps/forsite-capital-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio) ## Raising from investors like Foresite Capital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)